Log in

Relevant bibliographies by topics / Neridronic acid / Journal articles

To see the other types of publications on this topic, follow the link: Neridronic acid.

Journal articles on the topic 'Neridronic acid'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 15 journal articles for your research on the topic 'Neridronic acid.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "Neridronic acid." Reactions Weekly &NA;, no. 1309 (2010): 30. http://dx.doi.org/10.2165/00128415-201013090-00097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mollaamin, Fatemeh, and Majid Monajjemi. "Application of DFT/TD-DFT Frameworks in the Drug Delivery Mechanism: Investigation of Chelated Bisphosphonate with Transition Metal Cations in Bone Treatment." Chemistry 5, no. 1 (2023): 365–80. http://dx.doi.org/10.3390/chemistry5010027.

Full text

Abstract:

Carbon nanotubes (CNTs) are applied in a drug delivery system, which can be reacted with different structures such biomolecules. Bones have vital functions and are the locations of biochemical reactions in cells that might be exposed various diseases. As different metal ions are integral components of bone tissue with different functions in the physiological cellular medium as well as in bone treatment, they can be used differently as a basis or as a supplement for various materials in the field of bone repair. Therefore, this research aims to represent the recent progress in conjugated bispho

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "Neridronic acid is effective in treating malignant hypercalcaemia." Inpharma Weekly &NA;, no. 941 (1994): 11. http://dx.doi.org/10.2165/00128413-199409410-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Galantsev, A. V., D. V. Drobot, P. V. Dorovatovsky, and V. N. Khrustalev. "Lanthanum Complex with Neridronic Acid: Synthesis and Properties." Fine Chemical Technologies 14, no. 2 (2019): 70–77. http://dx.doi.org/10.32362/2410-6593-2019-14-2-70-77.

Full text

Abstract:

Currently, various amino bisphosphonates are widely used in the treatment of many bone diseases. One of the most well-known complex compounds of neridronic acid (6-amino-1-hydroxyhexylidene-1,1- bisphosphonic acid) is sodium neridronate – a bisphosphonate, which is used to treat osteogenesis and Paget's disease. However, there is no data on compounds of neridronic acid with rare earth elements. A new complex of lanthanum with 6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid (I) was obtained and characterized by various physicochemical methods (chemical analysis, IR spectroscopy, solid-phase

APA, Harvard, Vancouver, ISO, and other styles

5

Gatti, Davide, Ombretta Viapiana, Luca Idolazzi, Elena Fracassi, and Silvano Adami. "Neridronic acid for the treatment of bone metabolic diseases." Expert Opinion on Drug Metabolism & Toxicology 5, no. 10 (2009): 1305–11. http://dx.doi.org/10.1517/17425250903029190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Aderibigbe, B. A., E. R. Sadiku, S. Sinha Ray, et al. "Synthesis and characterization of polyamidoamine conjugates of neridronic acid." Polymer Bulletin 72, no. 3 (2014): 417–39. http://dx.doi.org/10.1007/s00289-014-1286-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nicolin, Vanessa, Renato Bareggi, Giovanna Baldini, Roberta Bortul, Bruno Martinelli, and Paola Narducci. "Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures." Acta Histochemica 109, no. 5 (2007): 397–402. http://dx.doi.org/10.1016/j.acthis.2007.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nicolin, V., P. Narducci, and B. Martinelli. "Neridronic acid directly regulates osteoblast proliferation and gene expression in human osteoblast cell line." Bone 44 (June 2009): S448. http://dx.doi.org/10.1016/j.bone.2009.03.420.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lurati, A. "Efficacy of Neridronic Acid IV and IM in Improving BMD and Reducing Fracture Risk in Postmenopausal Osteoporosis." International Journal of Biochemistry Research & Review 3, no. 3 (2013): 259–65. http://dx.doi.org/10.9734/ijbcrr/2013/4210.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fornari, Rachele. "Metabolic Characterization and Follow up of Adult Patients Affected by Osteogenesis Imperfecta in Long-term Treatment with Neridronic Acid." British Journal of Medicine and Medical Research 1, no. 4 (2011): 478–85. http://dx.doi.org/10.9734/bjmmr/2011/501.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

"Neridronic acid." Reactions Weekly 1704, no. 1 (2018): 278. http://dx.doi.org/10.1007/s40278-018-46921-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

"Neridronic-acid." Reactions Weekly 1931, no. 1 (2022): 464. http://dx.doi.org/10.1007/s40278-022-27261-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Fornari, Rachele, Paolo Sgro, Emanuela Greco, et al. "Metabolic Characterization and Follow up of Adult Patients Affected by Osteogenesis Imperfecta in Long-term Treatment with Neridronic Acid." September 23, 2011. https://doi.org/10.5281/zenodo.7798.

Full text

Abstract:

Aims: Osteogenesis imperfecta (OI) is a rare inherited disorder causing low bone density and increased fragility. Bisphosphonates (BP) are a treatment of choice for OI. Few studies have investigated the long-term effects of BP in OI patients. Thus, aim of our study was to follow up adults affected by OI to evaluate changes in metabolic, clinical situation and safety of long-term neridronic acid therapy, BP authorized for OI treatment. Study design: Longitudinal observational study. Place and duration of the Study: Department of Experimental Medicine, Section of Medical Pathophysiology, Endocri

APA, Harvard, Vancouver, ISO, and other styles

14

Borrelli, Angela Carla, Laura Capozzi, Massimiliano De Vivo, et al. "Treatment with Neridronic Acid in a Newborn with Severe and Refractory Hypercalcemia Associated with Subcutaneous Fat Necrosis." Journal of Neonatology, May 10, 2023, 097321792311662. http://dx.doi.org/10.1177/09732179231166280.

Full text

Abstract:

Neonatal subcutaneous fat necrosis (SCFN) is a transient, generally benign panniculitis that presents within several weeks of life and occurs mostly in term or post-term newborns who have a history of intrauterine or perinatal distress. It is usually a self-limited condition. Hypercalcemia is a rare but serious complication of SCFN and needs prolonged follow-up. The etiopathogenesis of both subcutaneous fat necrosis in newborn and the resultant hypercalcemia is poorly understood. We describe a classic presentation of SCFN that led to a severe hypercalcemia refractory to standard treatment. Thi

APA, Harvard, Vancouver, ISO, and other styles

15

"EYE ON CHINA." Asia-Pacific Biotech News 18, no. 07 (2014): 17–23. http://dx.doi.org/10.1142/s0219030314000469.

Full text

Abstract:

ScinoPharm and Lee's Pharmaceutical jointly develop drug products for the Chinese market. WuXi PharmaTech begins construction of new R&D and cGMP manufacturing campus in Changzhou. NeoStem signs Licensing Agreement with Cellular Biomedicine Group and plans to begin Phase 2 hepatocellular carcinoma trial in China. Abiogen Pharma signed agreement with Lee's Pharma to market Neridronic Acid in mainland China, Taiwan, Hong Kong and Macau. InSightec launches its first centers in China. Shuwen Biotech and DiagnoCure sign exclusive agreement for commercializing colorectal cancer staging test in C

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!